scholarly article | Q13442814 |
P8978 | DBLP publication ID | journals/bmcbi/BisginLFXT11 |
P6179 | Dimensions Publication ID | 1017224302 |
P356 | DOI | 10.1186/1471-2105-12-S10-S11 |
P932 | PMC publication ID | 3236833 |
P698 | PubMed publication ID | 22166012 |
P50 | author | Weida Tong | Q96475222 |
P2093 | author name string | Hong Fang | |
Zhichao Liu | |||
Xiaowei Xu | |||
Halil Bisgin | |||
P2860 | cites work | Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders | Q24558589 |
Timing of new black box warnings and withdrawals for prescription medications | Q28216033 | ||
Finding complex biological relationships in recent PubMed articles using Bio-LDA | Q28477467 | ||
Extraction of semantic biomedical relations from text using conditional random fields | Q28754563 | ||
Identifying biological concepts from a protein-related corpus with a probabilistic topic model | Q33233422 | ||
Using the literature-based discovery paradigm to investigate drug mechanisms | Q33359167 | ||
Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. | Q34010718 | ||
What is prescription labeling communicating to doctors about hepatotoxic drugs? A study of FDA approved product labeling | Q35837119 | ||
"Black box" 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk | Q36357738 | ||
Inside the black box: current policies and concerns with the United States Food and Drug Administration's highest drug safety warning system | Q37743401 | ||
Mapping adverse drug reactions in chemical space. | Q39881783 | ||
Fish oil, Raynaud's syndrome, and undiscovered public knowledge | Q69703977 | ||
How adverse drug reactions can play a role in innovative drug research | Q70992416 | ||
P921 | main subject | unsupervised learning | Q1152135 |
topic model | Q3532085 | ||
Topic modeling | Q96468792 | ||
P304 | page(s) | S11 | |
P577 | publication date | 2011-10-18 | |
P1433 | published in | BMC Bioinformatics | Q4835939 |
P1476 | title | Mining FDA drug labels using an unsupervised learning technique--topic modeling | |
P478 | volume | 12 Suppl 10 |
Q34062615 | A phenome-guided drug repositioning through a latent variable model |
Q110949995 | A systematic review on literature-based discovery workflow |
Q35051254 | A systems approach for analysis of high content screening assay data with topic modeling |
Q28078205 | An overview of topic modeling and its current applications in bioinformatics |
Q92656083 | Artificial Intelligence in Anesthesiology: Current Techniques, Clinical Applications, and Limitations |
Q35596642 | Case-based reasoning using electronic health records efficiently identifies eligible patients for clinical trials |
Q64940658 | Computational Advances in Drug Safety: Systematic and Mapping Review of Knowledge Engineering Based Approaches. |
Q36906830 | Deep Patient: An Unsupervised Representation to Predict the Future of Patients from the Electronic Health Records. |
Q35569693 | Discovering associations among diagnosis groups using topic modeling |
Q40098361 | FINDING POTENTIALLY UNSAFE NUTRITIONAL SUPPLEMENTS FROM USER REVIEWS WITH TOPIC MODELING. |
Q45945293 | Facilitating prediction of adverse drug reactions by using knowledge graphs and multi-label learning models. |
Q38608709 | From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources |
Q38209986 | Integrative approaches for predicting in vivo effects of chemicals from their structural descriptors and the results of short-term biological assays |
Q34436688 | Investigating drug repositioning opportunities in FDA drug labels through topic modeling |
Q36170276 | Leveraging graph topology and semantic context for pharmacovigilance through twitter-streams |
Q47219850 | Mining Adverse Events of Dietary Supplements from Product Labels by Topic Modeling |
Q34686845 | Mining FDA drug labels for medical conditions |
Q35005256 | Mining hidden knowledge for drug safety assessment: topic modeling of LiverTox as a case study |
Q30573306 | Multinomial modeling and an evaluation of common data-mining algorithms for identifying signals of disproportionate reporting in pharmacovigilance databases |
Q34538839 | Of text and gene--using text mining methods to uncover hidden knowledge in toxicogenomics |
Q36853573 | Predicting the Drug Safety for Traditional Chinese Medicine through a Comparative Analysis of Withdrawn Drugs Using Pharmacological Network |
Q34099736 | Proceedings of the 2011 MidSouth Computational Biology and Bioinformatics Society (MCBIOS) conference. Introduction |
Q34436560 | Proceedings of the 2012 MidSouth Computational Biology and Bioinformatics Society (MCBIOS) conference. Introduction. |
Q55963652 | Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases |
Q34549552 | Redundancy in electronic health record corpora: analysis, impact on text mining performance and mitigation strategies |
Q35097259 | Redundancy-aware topic modeling for patient record notes |
Q35097852 | Semantic processing to identify adverse drug event information from black box warnings |
Q55645213 | Semantic processing to identify adverse drug event information from black box warnings. |
Q64091947 | Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA |
Q48158859 | Systematic identification of latent disease-gene associations from PubMed articles |
Q35963529 | Text mining for identifying topics in the literatures about adolescent substance use and depression |
Q51429997 | Topic Modeling of Smoking- and Cessation-Related Posts to the American Cancer Society's Cancer Survivor Network (CSN): Implications for Cessation Treatment for Cancer Survivors Who Smoke. |
Q38187450 | Toward predictive models for drug-induced liver injury in humans: are we there yet? |
Q89782267 | Whole-Genome k-mer Topic Modeling AssociatesBacterial Families |
Search more.